Review of chemotherapy-associated paronychia

被引：7
|
作者：
Gupta, Mohit K. [1 ]
Lipner, Shari R. [2 ]
机构：
[1] State Univ New York Downstate, Coll Med, Brooklyn, NY USA
[2] Weill Cornell Med, Dept Dermatol, 1305 York Ave, New York, NY 10021 USA
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2022年 / 61卷 / 04期
关键词：
CELL LUNG-CANCER; OPEN-LABEL; PYOGENIC GRANULOMA; ERLOTINIB MONOTHERAPY; JAPANESE PATIENTS; PHASE-II; INHIBITOR; CETUXIMAB; TRIAL; MANAGEMENT;
D O I：
10.1111/ijd.15740
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Chemotherapy-associated paronychia (CAP) is an inflammation of the nail folds in response to various chemotherapeutic medications. Altered proliferation of keratinocytes or nail matrix stem cells is thought to be a major causative factor. Prophylactic tetracyclines, topical povidone-iodine, and general irritation avoidance measures are among some of the recommended interventions for CAP. Appropriate recognition and treatment of CAP are important for prevention of chemotherapy dose reduction or medication discontinuation.
引用
收藏
页码：410 / 415
页数：6
相关论文
共 50 条
  • [1] Chemotherapy-associated paronychia: Do not forget the children
    Borgia, Paola
    Piccolo, Gianluca
    Diana, Maria Cristina
    Viglizzo, Gianmaria
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 88 (01) : E59 - E59
  • [2] Chemotherapy-associated paronychia treated with a dilute povidone-iodine/dimethylsulfoxide preparation
    Capriotti, Kara
    Capriotti, Joseph A.
    [J]. CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2015, 8 : 489 - 491
  • [3] Chemotherapy-associated paronychia treated with 2% povidone-iodine: a series of cases
    Capriotti, Kara
    Capriotti, Joseph
    Pelletier, Jesse
    Stewart, Kevin
    [J]. CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 225 - 228
  • [4] Povidone-iodine nail solution is active in treating chemotherapy-associated paronychia
    Capriotti, Kara
    Capriotti, Joseph
    Lessin, Stuart
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB115 - AB115
  • [5] Chemotherapy-Associated Hepatotoxicities
    White, Michael A.
    Fong, Yuman
    Singh, Gagandeep
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 2016, 96 (02) : 207 - +
  • [6] Chemotherapy-associated pneumoperitoneum in cancer patients: a scoping review
    Maina, Renee M.
    Rader, Caroline
    Kypa, Jeevan
    Asahngwa, Constantine
    Jasmin, Hilary M.
    Zalamea, Nia N.
    Nelson, John S.
    Altomar, Jonathan L.
    Owens, Mary Brinson
    Muenyi, Clarisse S.
    Foretia, Denis A.
    [J]. ANNALS OF MEDICINE AND SURGERY, 2024, 86 (05): : 2828 - 2835
  • [7] Chemotherapy-associated steatohepatitis
    Meunier, Lucy
    Larrey, Dominique
    [J]. ANNALS OF HEPATOLOGY, 2020, 19 (06) : 597 - 601
  • [8] Chemotherapy-associated hematopoietic toxicity
    Kuhn, JG
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 : S4 - S7
  • [9] Chemotherapy-associated supravenous hyperpigmentation
    Baselga, E
    Drolet, BA
    Casper, J
    Esterly, NB
    [J]. DERMATOLOGY, 1996, 192 (04) : 384 - 385
  • [10] Treatment of chemotherapy-associated cardiomyopathy
    Cai, Amanda W.
    Taylor, Marian H.
    Ramu, Bhavadharini
    [J]. CURRENT OPINION IN CARDIOLOGY, 2019, 34 (03) : 296 - 302
12345